1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Earnings

Perrigo Q2 Results Down Nearly 11% On Formula Slump Despite Women’s Health Sales Jump On Opill

 
• By Malcolm Spicer

OTC private label/store brand product giant’s Q2 net sales down 10.7% to $1.1bn, but women’s health product sales jump 31.4% largely on Opill launched late in Q1. Biggest hit to results from infant formula business, down a reported 82% due to ongoing manufacturing quality-control remediation.

• Source: Shutterstock

The more Perrigo Company PLC has added to its consumer health portfolio, namely the first OTC daily oral contraceptive available in the US, the more it has been hit with lower revenues for some product lines and from some customers.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

US Q1 Consumer Health Earnings Preview: Concern Unavoidable For Impact From ‘T’ Word

 
• By Malcolm Spicer

Concern is unavoidable for most marketers of OTC drugs and dietary supplements in the US. As Canaccord Genuity analysts said in a 15 April research note, “uncertainty remains about how the tariff situation will play out.”

Euro Q1 Consumer Health Earnings Preview: Haleon, Reckitt, Bayer

 
• By Tom Gallen

Major Europe-based consumer health players Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q1 2025 results over the coming weeks.

Arkopharma Shakes Up Strategy As Supplement Market Competition Intensifies

 
• By Tom Gallen

Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.

Swisse Benefits As Supplements Considered ‘Daily Necessity’ In China

 
• By Tom Gallen

Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.

More from Business

US Consumer Health Market People News; BodyArmor, Just Ingredients, CRN/Radicle Award

 
• By Malcolm Spicer

CRN/Radicle Science expand Trailblazer Award nominations; BodyArmor brand relaunch with ‘Choose Better’ campaign and pro athletes; and Just Ingredients catches Bryce Harper as partner.

Abbott Lifts Curtain For Consumer Health Sector Results On ‘Dynamic Environment’ From Tariffs

 
• By Malcolm Spicer

“As we progress through 2025, it is clear that we are operating in an increasingly dynamic environment,” says Abbott CEO Robert Ford. Trump’s tariff decisions, the CRN advises dietary supplement and other consumer health product firms, are likely to change.

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.